EV Group successfully finalises an investment in Cornelius Group plc through a minority equity stake.
EV Group, a leading specialty chemicals and food ingredients distributor and manufacturer, and Cornelius Group (Cornelius), an international manufacturer and distributor of specialty additives and ingredients to the life sciences and performance chemicals markets, announce today that they have reached binding agreements for the acquisition by EV of a minority stake in Cornelius.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109291745/en/

Photographed (Left to Right): Darren Spiby, Joint CEO, Cornelius Group plc; Phillip Gibbons, Joint CEO, Cornelius Group plc; Dr Neville Prior, Group Chairman, Cornelius Group plc; Ludovico Balbo di Vinadio, Shareholder and Deputy Chairman, EV Group; Cristina Colombo, Chief Financial Officer, EV Group; Gabriele Bonomi, Chief Executive Officer, EV Group. (Photo: Business Wire)
Under the terms of the transaction, EV Group will increase its stake in Cornelius through additional equity acquisitions of Cornelius shares over the next two to three years.
Founded in 1935 by Dr Ernst Gustav Cornelius in London, Cornelius has a long history as a privately held European chemical manufacturer and distributor, and boasts an international reputation for its capabilities and technical expertise. Over the years, Cornelius has become the partner of choice for many international and local manufacturers in a variety of industries. Currently, Cornelius employs around 100 people and, in the financial year to 31 January 2024, generated a turnover of £42 million.
This partnership between EV Group and Cornelius Group will strengthen both businesses, leveraging their shared technical expertise and complementary strengths. For EV Group, Cornelius provides an established route to market in the UK and Poland, while Cornelius gains access to a broader range of products across manufacturing and distribution. Together, this collaboration will drive growth and support the delivery of Cornelius’ future vision.
The combined business will integrate EV Group's brand lines with Cornelius' offerings, creating a stronger portfolio of commercialised solutions across Life Sciences, Industrial, Medical, and Nutrition markets. With enhanced assets, expanded commercial infrastructure, and deep financial resources, the business is well-positioned to unlock new market opportunities.
Phillip Gibbons, CEO of Cornelius, said: “This partnership reinforces Cornelius’ position and provides the stability needed to execute our vision for the future. I have long admired EV’s entrepreneurial spirit and solid expertise in the chemical distribution sector, and I am delighted they so clearly support our long-term ambitions.”
Gabriele Bonomi, CEO of EV Group, commented: “We are delighted to invest in Cornelius Group to reinforce their position and support the growth of EV. Cornelius perfectly fits in with our strategy; it significantly enhances our capabilities and enriches our product portfolio. It further enhances our international presence.”
Cornelius will continue to focus on its core activities of providing innovative and sustainable solutions in the fields of Performance Chemicals, Life Sciences and the Ocular industry. The management of Cornelius will continue to lead the company to post-completion of this transaction.
EVGROUP
Founded in 1910, Eigenmann & Veronelli Group is an international solutions provider of specialty chemicals and food ingredients. Headquartered in Rho, Italy, EV has a direct presence in Italy, Iberia, Turkey, and the U.A.E. and a commercial reach in more than 40 countries. In 2024, EV generated a consolidated turnover of 347 million euros with more than 350 employees. With over a century of experience, EV is synonymous with effectiveness and efficiency, combining local market knowledge with chemical innovations, and offering a high-quality and diversified portfolio of specialty chemicals and food ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, and comprehensive regulatory know-how for a wide range of industries.
Follow us on LinkedIn.
CORNELIUS GROUP
Cornelius Group is an independent manufacturer and distributor of raw materials, ingredients and specialty chemicals for life science, performance chemicals and ocular sector operating in UK, Europe, Asia and USA. The core business values: We Lead, We Care, We Deliver are at the heart of the vision, strategy and everyday thinking to deliver differentiated outcomes for both customers and business partners. Cornelius has an active membership to the UN Global Compact, ISO accredited for Quality Management (9001:2015), Environmental Management Systems (14001:2015) and Occupational Health and Safety Management (45001).
Follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250109291745/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting samarbejder med Mercurial Minds om at forbedre mulighederne inden for digital transformation4.7.2025 01:10:00 CEST | Pressemeddelelse
Andersen Consulting udvider sit udbud af teknologidrevne løsninger med tilføjelsen af samarbejdsfirmaet Mercurial Minds (M.M.), et konsulentfirma inden for digital transformation, AI og IT med base i Pakistan. M.M. blev grundlagt i 2013 og tilbyder en række tjenester, der er designet til at hjælpe organisationer med at udvikle sig og skalere, herunder i forbindelse med deres digitale transformationsstrategi, AI-tjenester, it-rådgivning og udvikling af robuste mobil- og webbrugeroplevelser. Firmaet leverer end-to-end-løsninger – udformning af datadrevne køreplaner, udvikling af intelligent automatisering og levering af sikre mobil- og weboplevelser, der kan skaleres – skræddersyet til virksomheder, der ønsker at forbedre sine forbindelsesmulighederne og opnå indsigter i realtid. M.M. betjener en bred vifte af brancher med fokus på finans, telekommunikation og andre dataintensive sektorer. "Dette samarbejde er en katalysator," siger Nabeel Saiyer, administrerende direktør for M.M. "Vores
Global Tourism Surging Ahead of Economic Growth, With Visits to Hit 30 Billion by 20344.7.2025 01:00:00 CEST | Press release
The World Economic Forum report, in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, predicts a significant uptick in tourist trips across the globeThe tourism sector will contribute $16 trillion to global GDP (more than 11% of the global economy) by 2034, according to World Travel & Tourism Council estimates (WTTC)India and China will be responsible for more than 25% of all outbound travel by 2030 The World Economic Forum has today published a new report forecasting that the travel and tourism industry is projected to serve 30 billion tourist trips by 2034. Travel and Tourism at a Turning Point: Principles for Transformative Growth, produced in collaboration with Kearney and the Ministry of Tourism Saudi Arabia, reveals a projected $16 trillion contribution to global GDP by the same year—representing more than 11% of the total world economy, according to World Travel & Tourism Council estimates. The report also found that the sector is expanding 1.5 times faster th
The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 21:00:00 CEST | Press release
The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate
Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 14:59:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac
Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 14:05:00 CEST | Press release
In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom